Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Els Torreele

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Mutagenesis|April 28, 2012
Genotoxicity profile of fexinidazole--a drug candidate in clinical development for human African trypanomiasis (sleeping sickness)David Tweats, Bernadette Bourdin Trunz, Els Torreele
BMJ Global Health|February 25, 2021
How to ensure a needs-driven and community-centred vaccination strategy for COVID-19 in AfricaYap Boum Ii, Ali Ouattara, Els Torreele, et al.
BMJ Global Health|February 20, 2021
Can we do for other essential medicines what we are doing for the COVID-19 vaccine?Adrianna Murphy, Lilian Mbau, Martin McKee, et al.
BMJ (Clinical Research Ed.)|February 15, 2023
High drug prices are not justified by industry's spending on research and developmentAris Angelis, Roman Polyakov, Olivier J Wouters, et al.
Plos Medicine|June 23, 2006
To fully tackle the gang of four, needs-driven R & D is essentialEls Torreele, Catherine Royce, Robert Don, et al.
American Journal of Public Health|February 17, 2017
Engaging Human Rights in the Response to the Evolving Zika Virus EpidemicJennifer J K Rasanathan, Sarah MacCarthy, Debora Diniz, et al.
Kinetoplastid Biology and Disease|April 26, 2007
Consultative meeting to develop a strategy for treatment of cutaneous leishmaniasis. Institute Pasteur, Paris. 13-15 June, 2006Farrokh Modabber, Pierre A Buffet, Els Torreele, et al.
Lancet (London, England)|July 2, 2002
Drug development for neglected diseases: a deficient market and a public-health policy failurePatrice Trouiller, Piero Olliaro, Els Torreele, et al.
Antimicrobial Agents and Chemotherapy|September 14, 2011
Antitrypanosomal activity of fexinidazole, a new oral nitroimidazole drug candidate for treatment of sleeping sicknessMarcel Kaiser, Michael A Bray, Monica Cal, et al.
Lancet (London, England)|October 6, 2023
A gender-responsive Pandemic Accord is needed for a healthier, equitable futureShirin Heidari, Els Torreele, Ahmet Metin Gülmezoglu, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Mutagenesis|April 28, 2012
Genotoxicity profile of fexinidazole--a drug candidate in clinical development for human African trypanomiasis (sleeping sickness)David Tweats, Bernadette Bourdin Trunz, Els Torreele
BMJ Global Health|February 25, 2021
How to ensure a needs-driven and community-centred vaccination strategy for COVID-19 in AfricaYap Boum Ii, Ali Ouattara, Els Torreele, et al.
BMJ Global Health|February 20, 2021
Can we do for other essential medicines what we are doing for the COVID-19 vaccine?Adrianna Murphy, Lilian Mbau, Martin McKee, et al.
BMJ (Clinical Research Ed.)|February 15, 2023
High drug prices are not justified by industry's spending on research and developmentAris Angelis, Roman Polyakov, Olivier J Wouters, et al.
Plos Medicine|June 23, 2006
To fully tackle the gang of four, needs-driven R & D is essentialEls Torreele, Catherine Royce, Robert Don, et al.
American Journal of Public Health|February 17, 2017
Engaging Human Rights in the Response to the Evolving Zika Virus EpidemicJennifer J K Rasanathan, Sarah MacCarthy, Debora Diniz, et al.
Kinetoplastid Biology and Disease|April 26, 2007
Consultative meeting to develop a strategy for treatment of cutaneous leishmaniasis. Institute Pasteur, Paris. 13-15 June, 2006Farrokh Modabber, Pierre A Buffet, Els Torreele, et al.
Lancet (London, England)|July 2, 2002
Drug development for neglected diseases: a deficient market and a public-health policy failurePatrice Trouiller, Piero Olliaro, Els Torreele, et al.
Antimicrobial Agents and Chemotherapy|September 14, 2011
Antitrypanosomal activity of fexinidazole, a new oral nitroimidazole drug candidate for treatment of sleeping sicknessMarcel Kaiser, Michael A Bray, Monica Cal, et al.
Lancet (London, England)|October 6, 2023
A gender-responsive Pandemic Accord is needed for a healthier, equitable futureShirin Heidari, Els Torreele, Ahmet Metin Gülmezoglu, et al.
Pageof 6